VistaPharm, Inc. has voluntarily recalled 395,460 units of Nystatin Oral Suspension, an antifungal medication used to treat fungal infections in the mouth. This recall includes both individual 5mL cups (380,700 units) and 16 fl. oz. (480 mL) bubblegum-flavored bottles (14,760 units). The recall was initiated because testing revealed an impurity peak that exceeds the approved safety specifications, meaning the product contains degradation products or impurities at levels higher than allowed.
The presence of impurities above the approved limit may lead to reduced effectiveness of the medication or potential unexpected side effects, though this recall is classified as low risk.
Product return and refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.